A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
Not yet recruiting · NCT07301229 · Registry updated 2025-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC) | Not yet recruiting | Phase 2 | 2025-12-24 | NCT07301229 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Henlius Biotech | 58 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||